Interaction of the ARF tumor suppressor with cytosolic HSP70 contributes to its autophagy function

Julia Pimkina1, Maureen E Murphy

  • 1Program in Developmental Therapeutics, Philadelphia, PA, USA.

Insights

The tumor suppressor ARF (alternative reading frame) protein travels to mitochondria, a process mediated by HSP70. The drug PES blocks this, inhibiting ARF

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The tumor suppressor p14/p19 (ARF) gene is frequently mutated in human cancers.
  • ARF has been recently shown to localize to mitochondria and induce autophagy.
  • The mechanisms regulating ARF mitochondrial trafficking are currently unknown.

Purpose of the Study:

  • To identify mitochondrial ARF-binding proteins.
  • To elucidate the role of HSP70 in ARF mitochondrial localization.
  • To investigate the effect of 2-phenylethynesulfonamide (PES) on ARF function and cancer cell sensitivity.

Main Methods:

  • Mass spectrometry-based proteomics to identify ARF-binding proteins.
  • Cellular assays to track ARF localization and HSP70 interaction.
  • Analysis of autophagy induction and cell death in response to PES treatment.

Main Results:

  • Mitochondrial ARF was found to interact with HSP70.
  • PES treatment blocked ARF trafficking to mitochondria, implicating HSP70 in this process.
  • PES inhibited ARF-induced autophagy and showed preferential cytotoxicity towards cells with high ARF levels.

Conclusions:

  • HSP70 mediates the mitochondrial localization of ARF.
  • ARF's mitochondrial localization is critical for its role in inducing autophagy.
  • PES demonstrates potential as a targeted therapy for advanced cancers with high ARF expression.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...